PHCUF
Price
$5.87
Change
-$0.13 (-2.17%)
Updated
Aug 7 closing price
Capitalization
162.82M
SGIOF
Price
$19.00
Change
+$1.04 (+5.79%)
Updated
Sep 3 closing price
Capitalization
15.28B
Interact to see
Advertisement

PHCUF vs SGIOF

Header iconPHCUF vs SGIOF Comparison
Open Charts PHCUF vs SGIOFBanner chart's image
Photocure ASA
Price$5.87
Change-$0.13 (-2.17%)
Volume$1K
Capitalization162.82M
Shionogi & Co
Price$19.00
Change+$1.04 (+5.79%)
Volume$101
Capitalization15.28B
PHCUF vs SGIOF Comparison Chart in %
Loading...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHCUF vs. SGIOF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHCUF is a Hold and SGIOF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (PHCUF: $5.87 vs. SGIOF: $19.00)
Brand notoriety: PHCUF and SGIOF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PHCUF: 171% vs. SGIOF: 14%
Market capitalization -- PHCUF: $162.82M vs. SGIOF: $15.28B
PHCUF [@Pharmaceuticals: Generic] is valued at $162.82M. SGIOF’s [@Pharmaceuticals: Generic] market capitalization is $15.28B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHCUF’s FA Score shows that 1 FA rating(s) are green whileSGIOF’s FA Score has 2 green FA rating(s).

  • PHCUF’s FA Score: 1 green, 4 red.
  • SGIOF’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOF is a better buy in the long-term than PHCUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHCUF’s TA Score shows that 2 TA indicator(s) are bullish while SGIOF’s TA Score has 4 bullish TA indicator(s).

  • PHCUF’s TA Score: 2 bullish, 2 bearish.
  • SGIOF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both PHCUF and SGIOF are a good buy in the short-term.

Price Growth

PHCUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SGIOF (@Pharmaceuticals: Generic) price change was +5.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOF($15.3B) has a higher market cap than PHCUF($163M). PHCUF has higher P/E ratio than SGIOF: PHCUF (772.72) vs SGIOF (14.04). SGIOF YTD gains are higher at: 55.610 vs. PHCUF (4.907). SGIOF has higher annual earnings (EBITDA): 206B vs. PHCUF (44.5M). SGIOF has more cash in the bank: 576B vs. PHCUF (239M). PHCUF has less debt than SGIOF: PHCUF (0) vs SGIOF (11.7B). SGIOF has higher revenues than PHCUF: SGIOF (419B) vs PHCUF (523M).
PHCUFSGIOFPHCUF / SGIOF
Capitalization163M15.3B1%
EBITDA44.5M206B0%
Gain YTD4.90755.6109%
P/E Ratio772.7214.045,504%
Revenue523M419B0%
Total Cash239M576B0%
Total Debt011.7B-
FUNDAMENTALS RATINGS
PHCUF vs SGIOF: Fundamental Ratings
PHCUF
SGIOF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
922
PRICE GROWTH RATING
1..100
4842
P/E GROWTH RATING
1..100
637
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOF's Valuation (24) in the null industry is significantly better than the same rating for PHCUF (98). This means that SGIOF’s stock grew significantly faster than PHCUF’s over the last 12 months.

SGIOF's Profit vs Risk Rating (100) in the null industry is in the same range as PHCUF (100). This means that SGIOF’s stock grew similarly to PHCUF’s over the last 12 months.

SGIOF's SMR Rating (2) in the null industry is significantly better than the same rating for PHCUF (92). This means that SGIOF’s stock grew significantly faster than PHCUF’s over the last 12 months.

SGIOF's Price Growth Rating (42) in the null industry is in the same range as PHCUF (48). This means that SGIOF’s stock grew similarly to PHCUF’s over the last 12 months.

PHCUF's P/E Growth Rating (6) in the null industry is in the same range as SGIOF (37). This means that PHCUF’s stock grew similarly to SGIOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHCUFSGIOF
RSI
ODDS (%)
Bearish Trend 3 days ago
11%
Bearish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
37%
Bearish Trend 3 days ago
64%
Momentum
ODDS (%)
Bullish Trend 3 days ago
30%
Bullish Trend 3 days ago
51%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
29%
Bullish Trend 3 days ago
45%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
26%
Bullish Trend 3 days ago
51%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
35%
Aroon
ODDS (%)
Bearish Trend 3 days ago
22%
Bullish Trend 3 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HBANM22.970.22
+0.97%
Huntington Bancshares
AVTR13.310.12
+0.91%
Avantor
LOB38.36-0.29
-0.75%
Live Oak Bancshares
LSAK4.61-0.06
-1.28%
Lesaka Technologies
SNCR5.37-0.10
-1.83%
Synchronoss Technologies

PHCUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHCUF has been loosely correlated with HLTRF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PHCUF jumps, then HLTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHCUF
1D Price
Change %
PHCUF100%
N/A
HLTRF - PHCUF
38%
Loosely correlated
N/A
INCR - PHCUF
26%
Poorly correlated
+0.27%
ELAN - PHCUF
24%
Poorly correlated
+5.50%
MKKGY - PHCUF
22%
Poorly correlated
+1.66%
MKGAF - PHCUF
20%
Poorly correlated
+1.49%
More

SGIOF and

Correlation & Price change

A.I.dvisor tells us that SGIOF and ROMJF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOF and ROMJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOF
1D Price
Change %
SGIOF100%
N/A
ROMJF - SGIOF
8%
Poorly correlated
-4.79%
TEVJF - SGIOF
8%
Poorly correlated
N/A
SFOSF - SGIOF
6%
Poorly correlated
N/A
RGEDF - SGIOF
3%
Poorly correlated
N/A
PHCUF - SGIOF
-0%
Poorly correlated
N/A
More